Dr. Milev is actively involved in research in depression, bipolar disorder, and other mental disorders in Providence Care. His main areas of research include stigma, sleep architecture, psychopharmacological and rTMS treatments. Most recent focus of his research have been biomarkers for treatment response in depression, as part of the CAN-BIND integrated discovery program.
He is also the Director, Centre for Neuroscience Studies and Professor of Psychiatry and Psychology, Queen’s University and Vice President, Medical and Academic Affairs, Providence Care. Dr. Milev completed his medical degree in Sofia, Bulgaria in 1983, obtained Specialty of Psychiatry in Bulgaria, MRCPsych in England and FRCPC in Canada and defended a PhD in Forensic Psychiatry. In 1995 he moved to Regina, Canada, where he became Medical Director of the Mental Health Clinic.
In 2001 he was appointed Clinical Director of the Mood Disorder Research and Treatment Service in Kingston. From 2007 until 2017 he was the Head of Department of Psychiatry at Queen’s University and affiliated teaching hospitals.
He has been the Director of Centre for Neuroscience studies at Queen’s University since 2017. In October 2018, he was appointed as Vice President, Medical and Academic Affairs at Providence Care Hospital.
He is a Fellow of the Royal College of Psychiatrists (UK) and a Distinguished Fellow of both Canadian and American Psychiatric Associations.
Dr. Milev has over 200 peer reviewed publications and book chapters. He has led many symposia, workshops and panel discussions at conferences and has presented numerous lectures to psychiatrists, primary care providers and other health professionals.
Dr. Milev is actively involved in undergraduate, graduate and postgraduate teaching, including supervision of Masters and PhD students. He has co-authored several CANMAT guidelines for management of patients with Major Depressive Disorder and Bipolar Disorders. He has won several prizes and awards.